Eria Bwogi

Eria Bwogi

Auto-generated profile, based on publicly available information

Eria Bwogi

Department of Preventive Medicine, Korea University College of Medicine , 73, Goryeodae-ro, Seongbuk-gu, Seoul 02841

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 September 2026 in Journal of Radiation Research
Verified
Journal Article
Open access
JLJeeyoung Lee
Jeeyoung Lee
EPEun Jung Park
Eun Jung Park
EBEria Bwogi
Eria Bwogi
Nobuyuki HamadaNobuyuki Hamada
Nobuyuki Hamada
SSSung Ryul Shim
Sung Ryul Shim
WLWon Jin Lee
Won Jin Lee
Radiotherapy (RT) is an integral component of cancer treatment; however, it can expose surrounding healthy tissues, including the heart, to ionizing radiation. This study aimed to evaluate the dose–response relationship between mean heart dose (MHD) and cardiac disease and to estimate the attributable burden among breast cancer survivors. PubMed and Embase were searched from inception to 31 January 2026 for studies reporting relative risks (RRs) per gray (Gy). A random-effects meta-analysis was used to pool dose–response estimates. The attributable fraction (AF) and population attributable fraction (PAF) were estimated using pooled dose–response coefficients and representative MHD values. Thirteen studies involving 16 446 breast cancer survivors were included. The pooled RR per Gy increase in MHD was 1.09 (95% confidence interval, 1.05–1.13), with no significant differences across treatment periods. At a representative MHD of 3.39 Gy, the AF among irradiated patients was estimated at 24.3%, indicating that one-quarter of cardiac events may be attributable to radiation exposure to the heart. Assuming a RT utilization of 52.7%, the corresponding PAF among breast cancer survivors was 14.4%. Although MHD decreased from 7.03 Gy before 2000 to 2.57 Gy thereafter, the AF declined from 38.9 to 21.6%. Over the same periods, despite a modest increase in RT utilization (51.1–55.3%), the PAF decreased from 24.5 to 13.2%. Despite these reductions, a measurable burden of cardiac disease remains attributable to radiation, underscoring the importance of minimizing cardiac dose among breast cancer survivors.